Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome
- PMID: 15866070
- DOI: 10.1016/j.virol.2005.01.051
Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome
Abstract
RNA interference (RNAi) is the process by which double-stranded RNA (dsRNA) directs sequence-specific degradation of messenger RNA in animal and plant cells. In mammalian cells, RNAi can be triggered by 21-23 nucleotide duplexes of small interfering RNA (siRNA). Strategies to inhibit RNA virus multiplication based on the use of siRNAs have to consider the high genetic polymorphism exhibited by this group of virus. Here we described a significant cross-inhibition of foot-and-mouth disease (FMD) virus (FMDV) replication in BHK-21 cells by siRNAs targeted to various conserved regions (5'NCR, VP4, VPg, POL, and 3'NCR) of the viral genome. The results showed that siRNAs generated in vitro by human recombinant dicer enzyme gave an inhibition of 10- to 1000-fold in virus yield of both homologous (HKN/2002) and heterologous (CHA/99) isolates of FMDV serotype O at 48 h post-infection (hpi). The inhibition extended to at least 6 days post-infection. For serotype Asia1, the virus yield in YNBS/58-infected cells examined at 12, 24, and 48 hpi decreased by approximately 10-fold in cells pretreated with HKN/2002-specific siRNAs, but there was no significant decrease at 60 hpi. The inhibition was specific to FMDV replication, as no reduction was observed in virus yield of pseudorabies virus, an unrelated virus. Moreover, we also demonstrated an enhanced viral suppression could be achieved in BHK-21 cells with siRNA transfection after an infection had been established. These results suggested that siRNAs directed to several conserved regions of the FMDV genome could inhibit FMDV replication in a cross-resistance manner, providing a strategy candidate to treat high genetic variability of FMDV.
Similar articles
-
Evaluation of in vitro inhibitory potential of small interfering RNAs directed against various regions of foot-and-mouth disease virus genome.Biochem Biophys Res Commun. 2005 Apr 15;329(3):1133-8. doi: 10.1016/j.bbrc.2005.02.080. Biochem Biophys Res Commun. 2005. PMID: 15752771
-
Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo.J Virol. 2006 Apr;80(7):3559-66. doi: 10.1128/JVI.80.7.3559-3566.2006. J Virol. 2006. PMID: 16537624 Free PMC article.
-
Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus.Virology. 2005 May 10;335(2):222-31. doi: 10.1016/j.virol.2005.03.001. Virology. 2005. PMID: 15840521
-
Potential applications of siRNA in hepatitis C virus therapy.Curr Opin Investig Drugs. 2006 Feb;7(2):142-6. Curr Opin Investig Drugs. 2006. PMID: 16499284 Review.
-
Structural insights into replication initiation and elongation processes by the FMDV RNA-dependent RNA polymerase.Curr Opin Struct Biol. 2009 Dec;19(6):752-8. doi: 10.1016/j.sbi.2009.10.016. Epub 2009 Nov 13. Curr Opin Struct Biol. 2009. PMID: 19914060 Review.
Cited by
-
Suppression of prion protein in livestock by RNA interference.Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5285-90. doi: 10.1073/pnas.0600813103. Epub 2006 Mar 27. Proc Natl Acad Sci U S A. 2006. PMID: 16567624 Free PMC article.
-
Identification and characterization of buffalo 7SK and U6 pol III promoters and application for expression of short hairpin RNAs.Int J Mol Sci. 2014 Feb 14;15(2):2596-607. doi: 10.3390/ijms15022596. Int J Mol Sci. 2014. PMID: 24534805 Free PMC article.
-
The plasmid constructs producing shRNA corresponding to the conserved 3D polymerase of Foot and Mouth Disease virus protects guinea pigs against challenge virus.Vet Res Commun. 2009 Mar;33(3):263-71. doi: 10.1007/s11259-008-9174-3. Epub 2008 Sep 23. Vet Res Commun. 2009. PMID: 18810649
-
GalNAc-siRNA conjugates: Prospective tools on the frontier of anti-viral therapeutics.Pharmacol Res. 2021 Nov;173:105864. doi: 10.1016/j.phrs.2021.105864. Epub 2021 Aug 30. Pharmacol Res. 2021. PMID: 34474100 Free PMC article. Review.
-
Silencing of hepatitis A virus infection by small interfering RNAs.J Virol. 2006 Jun;80(11):5599-610. doi: 10.1128/JVI.01773-05. J Virol. 2006. PMID: 16699041 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources